Patents by Inventor Albert BRENNAUER

Albert BRENNAUER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250002544
    Abstract: The invention relates to PYY analogues having alanine at position 4, lysine at position 7, QRY as the C-terminal end and a half-life extending group. The analogues of the invention are soluble around pH 6 and 7. The invention also relates to pharmaceutical compositions comprising such PYY analogues, and to the medical use of the analogues.
    Type: Application
    Filed: June 24, 2024
    Publication date: January 2, 2025
    Inventors: Peter Wilhelm HAEBEL, Albert BRENNAUER, Charlotte Stahl MADSEN, Soren Ljungberg PEDERSEN, Stefan PETERS
  • Publication number: 20240279278
    Abstract: The present invention relates to NMU-8 analogues that are neuromedin U receptor 2 (NMUR2) agonists, processes for their preparation, pharmaceutical compositions comprising them and their use in therapy, particularly in the treatment or prevention of disease and/or condition associated with or modulated by NMUR2 activation such as obesity or obesity comorbidities.
    Type: Application
    Filed: January 11, 2024
    Publication date: August 22, 2024
    Inventors: Holger WAGNER, Angela BALJULS, Albert BRENNAUER, Thomas Siegfried FOX, Volker MACK, Stefan PETERS, Daniel Paul TEUFEL, Tina ZIMMERMANN
  • Patent number: 12054525
    Abstract: The invention relates to PYY analogues having alanine at position 4, lysine at position 7, QRY as the C-terminal end and a half-life extending group. The analogues of the invention are soluble around pH 6 and 7. The invention also relates to pharmaceutical compositions comprising such PYY analogues, and to the medical use of the analogues.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: August 6, 2024
    Assignee: Boehringer Ingelheim Internatioal GmbH
    Inventors: Peter Wilhelm Haebel, Albert Brennauer, Charlotte Stahl Madsen, Soren Ljungberg Pedersen, Stefan Peters
  • Publication number: 20230340039
    Abstract: The invention relates to PYY analogues having alanine at position 4, lysine at position 7, QRY as the C-terminal end and a half-life extending group. The analogues of the invention are soluble around pH 6 and 7. The invention also relates to pharmaceutical compositions comprising such PYY analogues, and to the medical use of the analogues.
    Type: Application
    Filed: December 20, 2022
    Publication date: October 26, 2023
    Inventors: Peter Wilhelm HAEBEL, Albert BRENNAUER, Charlotte Stahl MADSEN, Soren Ljungberg PEDERSEN, Stefan PETERS
  • Publication number: 20220041678
    Abstract: The invention relates to PYY analogues having alanine at position 4, lysine at position 7, QRY as the C-terminal end and a half-life extending group. The analogues of the invention are soluble around pH 6 and 7. The invention also relates to pharmaceutical compositions comprising such PYY analogues, and to the medical use of the analogues.
    Type: Application
    Filed: August 5, 2021
    Publication date: February 10, 2022
    Inventors: Peter Wilhelm HAEBEL, Albert BRENNAUER, Stefan PETERS, Charlotte Stahl MADSEN, Søren Ljungberg PEDERSEN
  • Publication number: 20210139548
    Abstract: The invention relates to PYY analogues having alanine at position 4, lysine at position 7, QRY as the C-terminal end and a half-life extending group. The analogues of the invention are soluble around pH 6 and 7. The invention also relates to pharmaceutical compositions comprising such PYY analogues, and to the medical use of the analogues.
    Type: Application
    Filed: November 10, 2020
    Publication date: May 13, 2021
    Inventors: Peter Wilhelm HAEBEL, Albert BRENNAUER, Charlotte Stahl MADSEN, Soren Ljungberg PEDERSEN, Stefan PETERS